1. Home
  2. TBPH vs THRM Comparison

TBPH vs THRM Comparison

Compare TBPH & THRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Theravance Biopharma Inc.

TBPH

Theravance Biopharma Inc.

HOLD

Current Price

$18.67

Market Cap

993.7M

Sector

Health Care

ML Signal

HOLD

Logo Gentherm Inc

THRM

Gentherm Inc

HOLD

Current Price

$36.99

Market Cap

1.1B

ML Signal

HOLD

Company Overview

Basic Information
Metric
TBPH
THRM
Founded
2013
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Auto Parts:O.E.M.
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
993.7M
1.1B
IPO Year
N/A
1993

Fundamental Metrics

Financial Performance
Metric
TBPH
THRM
Price
$18.67
$36.99
Analyst Decision
Strong Buy
Buy
Analyst Count
5
2
Target Price
$27.80
$39.00
AVG Volume (30 Days)
528.0K
188.3K
Earning Date
11-10-2025
10-23-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.58
0.99
Revenue
$80,327,000.00
$1,468,728,000.00
Revenue This Year
$70.78
$3.56
Revenue Next Year
N/A
$2.52
P/E Ratio
$32.28
$37.31
Revenue Growth
27.12
N/A
52 Week Low
$7.90
$22.75
52 Week High
$20.33
$41.09

Technical Indicators

Market Signals
Indicator
TBPH
THRM
Relative Strength Index (RSI) 57.92 53.19
Support Level $17.25 $36.70
Resistance Level $19.13 $37.89
Average True Range (ATR) 0.65 0.99
MACD -0.05 -0.01
Stochastic Oscillator 78.72 50.34

Price Performance

Historical Comparison
TBPH
THRM

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

About THRM Gentherm Inc

Gentherm Inc is an automotive parts manufacturer. The business activities of the group function through the Automotive and Medical segments. The vast majority of the firm's revenue comes from the Automotive segment, which includes automotive climate comfort systems, automotive cable systems, battery performance solutions, and automotive electronics and software systems. The medical segment is comprised of the results from the patient temperature management business in the medical industry. Its geographical segments are the United States, China, South Korea, Germany, Japan, the Czech Republic, and other countries.

Share on Social Networks: